同步癌症在乳腺癌患者的预后影响
Alexandru Oprita1, Horia Cotan2, Cornelia Nitipir3
1Oncology, Saint Nicholas Hospital, Pitesti, ROU.
Cureus
|October 2, 2024
概括
与乳腺癌诊断的同步癌症影响存活率. 双边乳腺癌提供了比其他同步癌症更好的结果,突出需要量身定制的查和治疗.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 癌症流行病学 癌症流行病学
背景情况:
- 与原发性乳腺癌同时诊断的同步癌症存在独特的预后挑战.
- 了解二次恶性瘤对乳腺癌患者治疗结果的影响对于有效管理至关重要.
研究的目的:
- 评估初始乳腺癌患者同步癌症诊断的预后意义.
- 分析特定部位的存活率和原发性乳腺癌和二次性癌症之间的关系.
主要方法:
- 在两个月内,对49名被诊断患有原发性乳腺癌和同步性二次癌症的患者进行了回顾性分析.
- 数据包括人口统计,临床/病理特征,治疗和随访结果.
- 统计分析使用卡普兰-梅尔曲线和考克斯回归模型.
主要成果:
- 逆侧乳腺癌 (44.9%) 和女性生殖器官癌症 (12.24%) 是最常见的同步恶性瘤.
- 同步双边乳腺癌患者的整体生存期 (33个月) 与其他同步癌症 (23.5个月) 相比有所改善.
- 同步的非乳腺癌显著增加了死亡风险 (HR=1.6,p=0.003).
结论:
- 同步癌症诊断显著影响乳腺癌的预后.
- 与其他同步癌症相比,同步双边乳腺癌与更好的生存率有关.
- 研究结果强调需要对同步恶性瘤患者进行警的查和个性化治疗.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancer
48.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.1K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


